OPPILAN PHARMA
Oppilan Pharma is a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for the treatment of autoimmune diseases. Oppilan Pharma's lead drug candidate, OPL-002, is a potent and selective modulator of sphingosine 1 phosphate receptor subtype 1 (S1P1) under development for the treatment of inflammatory bowel disease. The company initiated a Phase 1 clinical study with OPL-002 in December 2018.
OPPILAN PHARMA
Social Links:
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2015-01-01
Address:
Altrincham, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oppilan.com
Total Employee:
11+
Status:
Active
Contact:
858-945-2393
Total Funding:
4.25 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail PHP GoDaddy DNS Person Schema Fastly Hosted Fastly Load Balancer Barracuda Networks
Similar Organizations
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Anacor Pharmaceutical
Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Lead Pharma
Lead Pharma discovers and develops innovative small-molecule drugs for the treatment of autoimmune diseases and cancer.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Neurimmune Holding
Neurimmune develops innovative immunotherapeutics for human diseases.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Nykode
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Employees Featured
Founder
Official Site Inspections
http://www.oppilan.com
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
